Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,211

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,841

Class I recallsReasonable probability of serious health consequences

24,366

Class II recallsTemporary or medically reversible health consequences

2,892

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of assurance of sterility 2,073 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/frutas-y-hortalizas-del-sur-sa-expands-recalls-include-additional-lots-great-value-frozen-organicPublished October 2, 2026

Most affected stateHawaii 200 recalls mention this state

State: ND ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 3, 2026 ET

Summary (Year to date)

1,714 recalls have been announced year to date.
Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (297).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,366
Class I	9,841
Class III	2,892
Not Yet Classified	2

Recalls by class
Class	Recalls
Class II	24,366
Class I	9,841
Class III	2,892
Not Yet Classified	2

FDA Recall Terminated Historical recordClass II

Lloyd Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lloyd Thyro-Tab 0.100 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lloyd Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levothroid (levothyroxine sodium tablets, USP), 88 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1329-01

by Lloyd Inc. of Iowa

Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lloyd Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levothroid (levothyroxine sodium tablets, USP) , 75 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1322-01

by Lloyd Inc. of Iowa

Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Lloyd Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

by Lloyd Inc. of Iowa

Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levothroid (levothyroxine sodium tablets, USP) , 50 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1321-01

by Lloyd Inc. of Iowa

Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b) 1000-count bottles (NDC 60793-860-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

by King Legacy, a wholly owned subsidiary of Pfizer

Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles (NDC 60793-859-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

by King Legacy, a wholly owned subsidiary of Pfizer

Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b) 1000-count bottles (NDC 60793-858-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

by King Legacy, a wholly owned subsidiary of Pfizer

Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles (NDC 60793-857-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

by King Legacy, a wholly owned subsidiary of Pfizer

Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b) 1000-count bottles (NDC 60793-856-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

by King Legacy, a wholly owned subsidiary of Pfizer

Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and b) 1000-count bottles (NDC 60793-855-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

by King Legacy, a wholly owned subsidiary of Pfizer

Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and b) 1000-count bottles (NDC 60793-854-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

by King Legacy, a wholly owned subsidiary of Pfizer

Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b) 1000-count bottles (NDC 60793-853-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

by King Legacy, a wholly owned subsidiary of Pfizer

Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b) 1000-count bottles (NDC 60793-852-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

by King Legacy, a wholly owned subsidiary of Pfizer

Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) 1000-count bottles (NDC 60793-851-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

by King Legacy, a wholly owned subsidiary of Pfizer

Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and b) 1000-count bottles (NDC 60793-850-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620

by King Legacy, a wholly owned subsidiary of Pfizer

Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
Published: May 29, 2013
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJ 07054, NDC 0067-6171-85

by Novartis Consumer Health

Reason: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.
Published: May 29, 2013
Distribution: Nationwide

View recall →

Data last updated: October 3, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.